Skip to main content
SpringerLink
Log in

Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases

  • Original Articles
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Viral hepatic diseases, especially those induced by the hepatitis B virus, can progress into more serious pathological outcomes and eventually to hepatocellular carcinoma. A growing body of evidence indicates that many trace elements play important roles in a number of carcinogenic processes that proceed through various mechanisms. To examine the status of trace elements during the development of hepatic carcinoma, we determined the selenium, iron, copper, and zinc levels and copper-to-zinc ratios in the serum of patients at different stages of viral hepatic disease. We observed significant changes in the selenium, iron copper, and zinc levels in the serum of patients having hepatocellular carcinoma, relative to those of healthy controls (p<0.05). The mean serum copper level in patients with hepatocellular carcinoma was significantly higher than that of the control group. In contrast, the mean selenium, iron, and zinc levels in patients having hepatocellular carcinoma were significantly lower than those of the control group. In addition, the mean zinc level in the serum of patients with hepatic cirrhosis was significantly lower than that of the control group (p<0.05). Moreover, we found markedly elevated Cu: Zn ratios (p<0.05) in patients having hepatic cirrhosis or hepatocellular carcinoma. Our findings imply that the levels of some trace elements, such as selenium, iron, copper, and zinc, and Cu:Zn ratios, might serve as biomarkers for the increased severity of viral hepatic damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. J. Alter and E. E. Mast, The epidemiology of viral hepatitis in the United States, Gastroenterol. Clin. North Am. 23, 437–455 (1994).

    PubMed  CAS  Google Scholar 

  2. P. Pisani, M. Parkin, F. Bray, and J. Ferlay, Estimates of the worldwide mortality from 25 cancers in 1990, Int. J. Cancer 83, 18–29 (1999).

    Article  PubMed  CAS  Google Scholar 

  3. K. Huang and S. Lin, Nationwide vaccination: a success story in Taiwan, Vaccine 18, 35–38 (2000).

    Article  Google Scholar 

  4. D. S. Chen, G. C. Kuo, J. L. Sung, et al., Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience, J. Infect. Dis. 162, 817–822 (1990).

    PubMed  CAS  Google Scholar 

  5. H. H. Lin, T. Y. Lee, D. S. Chen, et al., Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus, J. Pediatr. 111, 877–881 (1987).

    Article  PubMed  CAS  Google Scholar 

  6. H. M. Hsu, Epidemiology of Hepatitis B Virus Infection: Taiwan and Promotion with Assessment of Immunoprophylaxis, Hon-Chiang, Taipei, pp. 19–30 (1990).

    Google Scholar 

  7. H. H. Lin, J. H. Kao, T. C. Chand, H. Y. Hsu, and D. S. Chen, Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan, J. Med. Virol. 69, 466–470 (2003).

    Article  PubMed  Google Scholar 

  8. R. P. Beasley and C. C. Lin, Hepatitis B virus: the major etiology of hepatocellular carcinoma, Cancer 61, 1942–1956 (1986).

    Article  Google Scholar 

  9. E. N. Drake and H. H. Sky-Peck, Discriminant analysis of trace element distribution in normal and malignant human tissues, Cancer Res. 49, 4210–4215 (1989).

    PubMed  CAS  Google Scholar 

  10. H. H. Sky-Peck, Trace metals and neoplasia, Clin. Physiol. Biochem. 4, 99–111 (1986).

    PubMed  CAS  Google Scholar 

  11. S. B. Goldhabe, Trace element risk assessment: essentiality vs. toxicity, Regul. Toxicol. Pharmacol. 38, 232–242 (2003).

    Article  CAS  Google Scholar 

  12. M. Zowczak, M. Iskra, L. Torlinski, and S. Cofta, Analysis of serum copper and zinc concentrations in cancer patients, Biol. Trace Element Res. 82, 1–8 (2001).

    Article  CAS  Google Scholar 

  13. M. Kucharzewski, J. Braziewicz, U. Majewska, and S. Gozdz, Selenium, copper and zinc concentrations in intestinal cancer tissue and in colon and rectum polyps, Biol. Trace Element Res. 92, 1–10 (2003).

    Article  CAS  Google Scholar 

  14. M. W. Yu, I. S. Horng, K. H. Hsu, Y. C. Chiang, Y. F. Liaw, and C. J. Chen Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic virus infection, Am. J. Epidemiol. 150, 367–374 (1999).

    PubMed  CAS  Google Scholar 

  15. J. Y. N. Lau and T. L. Wright, Molecular virology and pathogenesis of hepatitis B, Lancet 342, 1335–1340 (1993).

    PubMed  CAS  Google Scholar 

  16. A. Nakayama, H. Fukuda, M. Ebara, H. Hamasaki, K. Nakajima, and H. Sakurai A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels, Biol. Pharm. Bull. 25, 426–431 (2002).

    Article  PubMed  CAS  Google Scholar 

  17. C. Barandier, S. Tanguy, S. Pucheu, F. Boucher, and J. De Leiris, Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress, Ann. NY Acad. Sci. 874, 138–155 (199).

  18. B. Sancak, A. Ünal, S. Candan, U. Coşkun, and N. Günel, Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages, J. Trace Elements Exp. Med. 16, 87–94 (2003).

    Article  CAS  Google Scholar 

  19. M. P. Rayman, The importance of selenium to human health, Lancet 356, 233–241 (2000).

    Article  PubMed  CAS  Google Scholar 

  20. G. N. Schrauzer, Anticarcinogenic effects of selenium, Cell Mol. Life Sci. 57, 1864–1873 (2000).

    Article  PubMed  CAS  Google Scholar 

  21. M. B. Irmak, G. Ince, M. Ozturk, and R. Cetin-Atalay, Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Res. 63, 6707–6715 (2003).

    PubMed  CAS  Google Scholar 

  22. J. E. Spallholz, L. M. Boylan, and H. S. Larsen, Advances in understanding selenium's role in the immune system, Ann. NY Acad. Sci. 587, 123–139 (1990).

    PubMed  CAS  Google Scholar 

  23. E. W. Taylor, R. G. Nadimpalli, and C. S. Ramanathan, Genomic structures of viral agents in relation to the biosynthesis of selenoproteins, Biol. Trace Element Res. 56, 63–91 (1997).

    CAS  Google Scholar 

  24. F. Fernandez-Banares, E. Cabre, M. Esteve, et al., Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status, Am. J. Gastroenterol. 97, 2103–2108 (2002).

    PubMed  CAS  Google Scholar 

  25. G. Gur, Y. Bayraktar, D. Ozer, M. Ozdogan, and B. Kayhan, Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus, Hepato-Gasteroenterology 45, 472–476 (1998).

    CAS  Google Scholar 

  26. D. G. Barceloux. Zinc, Clin. Toxicol. 37, 279–292 (1999).

    Article  CAS  Google Scholar 

  27. S. R. Powell, The antioxidant properties of zinc, J. Nutr. 130, 1447–1454 (2000).

    Google Scholar 

  28. N. Takeaki, T. Hitoshi, H. Yoshiaki, et al., The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients, Biol. Trace Element Res. 58, 65–76 (1997).

    Article  Google Scholar 

  29. E. Ho, Zinc deficiency, DNA damage and cancer risk, J. Nutr. Biochem. 15, 572–578 (2004).

    Article  PubMed  CAS  Google Scholar 

  30. T. Wu, C. T. Sempos, J. L. Freudenheim, P. Muti, and E. Smit, Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann. Epidemiol. 14, 195–201 (2004).

    Article  PubMed  Google Scholar 

  31. K. Grüngreiff, Zinc in liver disease, J. Trace Elements Exp. Med. 15, 67–78 (2002).

    Article  CAS  Google Scholar 

  32. P. K. Eagon, A. G. Teepe, M. S. Elm, et al., Hepatic hyperplasia and cancer in rats: alterations in copper metabolism, Carcinogenesis 20, 1091–1096 (1999).

    Article  PubMed  CAS  Google Scholar 

  33. M. Zowczak, M. Iskra, L. Torlinski, and S. Cofta, Analysis of serum copper and zinc concentrations in cancer patients, Biol. Trace Element Res. 82, 1–8 (2001).

    Article  CAS  Google Scholar 

  34. B. Florianczyk, Copper and metallothioneins in cancer cells, Ann. Univ. Mariae Curie Sklodowska 58, 390–393 (2003).

    Google Scholar 

  35. V. L. Goodman, G. J. Brewer, and S. D. Merajver, Copper deficiency as an anti-cancer strategy, Endocr. Relat. Cancer 11, 255–263 (2004).

    Article  PubMed  CAS  Google Scholar 

  36. T. U. Ciftci, B. Ciftci, O. Yis, Y. Guney, A. Bilgihan, and M. Ogretensoy, Changes in serum selenium, copper, zinc levels and cu/zn ratio in patients with pulmonary tuberculosis during therapy, Biol. Trace Element Res. 95, 65–71 (2003).

    Article  CAS  Google Scholar 

  37. J. L. Poo, R. Rosas-Romero, A. C. Montemayor, F. Isoard, and M. Uribe, Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study, J. Gastroenterol. 38, 45–51 (2003).

    Article  PubMed  Google Scholar 

  38. H. Canatan, I. Bakan, M. Akbulut, et al. Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects, Biol Trace Element Res. 100, 117–123 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Fooyin University Hospital, Pingtong, Taiwan

    Ching-Chiang Lin

  2. Basic Medical Science Education Center, Fooyin University Hospital, Pingtong, Taiwan

    Ching-Chiang Lin

  3. Department of Internal Medicine, Fooyin University Hospital, Pington, Taiwan

    Jee-Fu Huang

  4. Faculty of Biomedical Laboratory Science, Kaohsiung Medical University, Kaohsiung, Taiwan

    Li-Yu Tsai & Yeou-Lih Huang

Authors
  1. Ching-Chiang Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jee-Fu Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li-Yu Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yeou-Lih Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, CC., Huang, JF., Tsai, LY. et al. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res 109, 15–23 (2006). https://doi.org/10.1385/BTER:109:1:015

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:109:1:015

Index Entries

Search

Navigation